RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 146 filers reported holding RECURSION PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.32 and the average weighting 2.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,170,658 | +111.7% | 806,622 | +106.7% | 0.00% | – |
| Q2 2023 | $2,915,011 | +68.5% | 390,229 | +50.5% | 0.00% | – |
| Q1 2023 | $1,729,978 | -32.7% | 259,367 | -22.2% | 0.00% | – |
| Q4 2022 | $2,568,748 | -12.5% | 333,171 | +20.7% | 0.00% | – |
| Q3 2022 | $2,937,000 | +62.7% | 275,942 | +24.5% | 0.00% | – |
| Q2 2022 | $1,805,000 | +79.2% | 221,704 | +57.7% | 0.00% | – |
| Q1 2022 | $1,007,000 | -49.1% | 140,597 | +21.7% | 0.00% | – |
| Q4 2021 | $1,978,000 | +787.0% | 115,501 | +1090.7% | 0.00% | – |
| Q3 2021 | $223,000 | +443.9% | 9,700 | +753.9% | 0.00% | – |
| Q2 2021 | $41,000 | – | 1,136 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Obvious Management Services, L.L.C. | 5,977,631 | $42,800,000 | 100.00% |
| Two Sigma Ventures, LP | 1,806,800 | $12,937,000 | 74.73% |
| DCVC Opportunity Fund II GP, LLC | 3,951,141 | $28,290,000 | 31.54% |
| MV Management XI, L.L.C. | 1,971,908 | $14,119,000 | 9.80% |
| Data Collective IV GP, LLC | 5,941,120 | $42,538,000 | 9.03% |
| ArchPoint Investors | 1,267,430 | $9,075,000 | 3.13% |
| MIC Capital Management UK LLP | 1,388,889 | $9,944,000 | 1.94% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $10,806,000 | 1.09% |
| Samsara BioCapital, LLC | 539,236 | $3,861,000 | 0.97% |
| Pinz Capital Management, LP | 142,168 | $1,018,000 | 0.64% |